Copyright © 2008 Cell Press. All rights reserved.
Immunity, Vol 28, 440-444, 11 April 2008
Commentary
Cytokines as Therapeutic Targets: Advances and Limitations
1 Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
∗Corresponding author
Josef S. Smolen
josef.smolen@meduniwien.at
Summary
Biological therapies targeting cytokines, T cells, or B cells have improved outcomes of inflammatory diseases. However, many issues remain open: What is the best target? How well can response be predicted? How can cure be achieved?
Articles that cite this article
- The Roaring Twenties
Richard M. Locksley
Immunity, 2008, 28:4:437-439[Summary] [Full Text] [PDF]
